What is JFL Life Sciences Ltd (JFLLIFE) share price return in the past 10 years?

Data is not available for this company

What is the share price of JFL Life Sciences Ltd (JFLLIFE)?

Company share prices are keep on changing according to the market conditions. The current trading price of JFL Life Sciences Ltd (JFLLIFE) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of JFL Life Sciences?

The latest standalone P/E ratio of JFL Life Sciences as of 01-Jan-1970 is 5.10.

What is the P/B ratio of JFL Life Sciences Ltd (JFLLIFE)?

The latest standalone P/B ratio of JFL Life Sciences Ltd (JFLLIFE) as of 01-Jan-1970 is 0.74.

What is the 52-week high and low of JFL Life Sciences Ltd (JFLLIFE)?

The 52-week high of JFL Life Sciences Ltd (JFLLIFE) is Rs. 0.00 and the 52-week low is Rs. 0.00.

JFL Life Sciences Ltd (JFLLIFE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: JFL Life Sciences Ltd (JFLLIFE)
Brand: JFL Life Sciences

JFL Life Sciences Ltd (JFLLIFE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: JFLLIFE Pharmaceuticals & Drugs | Small Cap | JFL Life Sciences Share Price

JFL Life Sciences Ltd (JFLLIFE)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: JFLLIFE Pharmaceuticals & Drugs | Small Cap | JFL Life Sciences Share Price

Key Metrics

Valuation Multiples

Market Cap

₹33 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹1.9

TTM Sales

₹131 Cr.

Book Value per Share

₹13.4

P/E Ratio

5.10

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

0.74

Lower than its 5-year historical median

Price to Sales (P/S)

0.25

Lower than its 5-year historical median

EV/EBITDA

4.49

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

11.09%

Outperforms industry median

Return on Capital Employed (ROCE)

15.81%

Outperforms industry median

Return on Assets (ROA)

6.47%

Operating Profit Margin

10%

Net Profit Margin

5.07%

Gross Profit Margin

8.7%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

76.24%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

79.04%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

26.06%

Asset Quality

Promoter Holding

67.47%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹11 Cr.

Equity

₹33 Cr.

Face Value

₹10

All Time Low / High

- / -

JFL Life Sciences stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is JFL Life Sciences Ltd a good quality company?

JFL Life Sciences Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does JFL Life Sciences Ltd performance compare with that of its Peers?

Q.1 Revenue growth of JFL Life Sciences Ltd vs industry peers?

JFL Life Sciences Ltd revenue CAGR is 22.15%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of JFL Life Sciences Ltd?

Promoters hold 67.47% of the JFL Life Sciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of JFL Life Sciences Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -39.37% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	8.7%	11.8%	10.3%	23.1%	15.5%	11.5%	15.8%	-
Value Creation Index ⓘ	-0.4	-0.2	-0.3	0.7	0.1	-0.2	0.1	-
Growth Parameters ⓘ
Sales ⓘ	31.8	30.2	32.8	33.6	42.8	46.6	82	131
Sales YoY Gr.	-	-5.1%	8.6%	2.5%	27.5%	8.7%	76.2%	-
Adj EPS ⓘ	0.2	0.2	0.3	1.2	0.9	1	1.3	1.9
YoY Gr.	-	22.2%	27.3%	314.3%	-26.7%	17.7%	26%	-
BVPS (₹) ⓘ	3	3.3	3.6	4.7	9.8	10.8	12	13.4
Adj Net Profit ⓘ	0.3	0.4	0.5	2.8	2.8	3.3	4.2	6
Cash Flow from Ops. ⓘ	-3	3.2	-5.9	2.3	-9.1	8.4	-3.5	-
Debt/CF from Ops. ⓘ	-2.8	2.9	-2.9	6.8	-0.8	0.7	-3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	22.2%	34.7%	76.2%
Adj EPS ⓘ	NA	41.8%	2.8%	26%
BVPSⓘ	NA	29.7%	36.6%	11%
Share Price	-	-	-36.9%	-49.6%

Key Financial Parameters ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	6	6.9	8.8	30.6	12.9	9.7	11.1	15.3
Op. Profit Mgn % ⓘ	4.2	6.2	6.6	16	9.2	9.8	10	8.9
Net Profit Mgn % ⓘ	1	1.2	1.6	8.3	6.6	7.1	5.1	4.9
Debt to Equity ⓘ	1.7	1.7	2.5	1.4	0.2	0.2	0.3	0.2
Working Cap Days ⓘ	0	197	231	345	354	337	230	88
Cash Conv. Cycle ⓘ	0	103	108	172	182	213	148	37

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	31.78	30.17	32.77	33.59	42.83	46.55	82.04
Operating Expenses ⓘ +	30.46	28.31	30.61	28.23	38.90	41.97	73.84
Manufacturing Costs	0.18	0.30	0.19	0.30	0.34	0.48	0.48
Material Costs	29.13	26.46	28.91	25.80	35.71	39.95	66.11
Employee Cost	0.96	1.25	0.98	1.43	1.83	0.91	1.01
Other Costs ⓘ	0.19	0.31	0.53	0.70	1.02	0.62	6.25
Operating Profit ⓘ	1.32	1.86	2.16	5.36	3.93	4.58	8.20
Operating Profit Margin (%)	4.2%	6.2%	6.6%	16.0%	9.2%	9.8%	10.0%
Other Income ⓘ +	0	0.03	0.09	0.89	1.64	0.51	0.01
Exceptional Items ⓘ	0	0	0	0	0	0	0
Interest ⓘ	0.75	1.16	1.23	2.08	1.42	0.86	1.08
Depreciation ⓘ	0.15	0.24	0.28	0.37	0.43	0.44	0.99
Profit Before Tax ⓘ	0.42	0.50	0.75	3.80	3.72	3.79	6.14
Tax ⓘ	0.12	0.14	0.20	0.99	0.91	0.49	1.98
Profit After Tax	0.30	0.36	0.54	2.81	2.81	3.30	4.16
PAT Margin (%)	1.0%	1.2%	1.7%	8.4%	6.6%	7.1%	5.1%
Adjusted EPS (₹)	0.2	0.2	0.3	1.2	0.9	1.0	1.3
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	8.30%	0%

Valuation of JFL Life Sciences - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	5.01	5.38	6.87	11.29	32.27	35.58	39.46
Share Capital ⓘ	0.42	0.42	0.50	8.02	11	11	33
Reserves ⓘ	4.59	4.95	6.38	3.27	21.27	24.58	6.46
Debt +	6.93	7.64	13.60	13.79	7.18	5.11	10.16
Long Term Debt	2.90	1.31	8.18	8.41	1.39	0.40	0.38
Short Term Debt	4.04	6.33	5.42	5.38	5.79	4.71	9.78
Minority Interest	0	0	0	0	0	0	0
Trade Payables	1.42	8.82	4.57	15.44	7.39	12.51	17.76
Others Liabilities ⓘ	2.78	2.49	3.96	7.74	2.22	3.38	4.54
Total Liabilities ⓘ	16.15	24.33	29.01	48.26	49.06	56.59	71.91
Fixed Assets
Net Fixed Assets ⓘ +	2.48	5.05	6.50	7.13	6.80	12.47	12.24
Gross Block	3.25	6.06	7.79	8.83	8.92	13.08	13.83
Accumulated Depreciation	0.77	1.01	1.28	1.70	2.12	0.60	1.59
CWIP ⓘ	0.04	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0
Inventories	1.71	3.75	5.74	14.96	12.72	15.83	23.24
Trade Receivables	9.66	12.66	11.81	19.80	22.48	25.85	34.95
Cash Equivalents	0.03	0.30	0.04	0.19	0.06	0.44	0.06
Others Assets ⓘ	2.24	2.56	4.93	6.18	6.99	1.99	1.43
Total Assets ⓘ	16.15	24.33	29.01	48.26	49.06	56.59	71.91

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	-3	3.21	-5.87	2.32	-9.07	8.41	-3.53
PBT ⓘ	0.42	0.50	0.75	3.80	3.72	3.80	6.13
Adjustment ⓘ	0.80	1.33	1.41	2.44	1.85	1.28	2.07
Changes in Working Capital ⓘ	-4.21	1.47	-7.93	-4.05	-13.64	3.4	-10.71
Tax Paid ⓘ	-0.01	-0.08	-0.09	0.13	-1	-0.07	-1.02
Cash Flow From Investing Activity ⓘ +	-0.61	-2.76	-1.64	-0.71	0.87	-6.09	-0.01
Capex	-0.61	-2.78	-1.72	-1.69	0.24	-6.11	-0.40
Net Investments	0	0	0	0.88	0.62	0	0.38
Others ⓘ	0	0.02	0.08	0.10	0.02	0.03	0.01
Cash Flow From Financing Activity ⓘ +	3.61	-0.19	7.25	-1.46	8.07	-2.35	3.54
Net Proceeds from Shares ⓘ	0.70	0	0.96	1.56	18.17	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0.23	-7.02	-0.41	-0.02
Interest Paid ⓘ	-0.63	-1.10	-1.20	-2.08	-1.42	-0.86	-1.08
Dividend Paid ⓘ	0	0	0	0	0	0	-0.28
Others ⓘ	3.54	0.92	7.49	-1.17	-1.65	-1.07	4.92
Net Cash Flow ⓘ	-0	0.27	-0.26	0.15	-0.13	-0.03	-0

Financial Ratio

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	6.03	6.94	8.85	30.94	12.9	9.73	11.09
ROCE (%)	8.71	11.8	10.32	23.14	15.45	11.53	15.81
Asset Turnover Ratio	1.97	1.49	1.23	0.87	0.88	0.88	1.28
PAT to CFO Conversion(x)	-10	8.92	-10.87	0.83	-3.23	2.55	-0.85
Working Capital Days
Receivable Days	110.90	135	136.20	171.70	180.20	189.50	135.20
Inventory Days	19.60	33	52.80	112.40	118	112	86.90
Payable Days	17.80	70.60	84.50	141.50	116.70	90.90	83.60

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JFL Life Sciences Ltd FAQs

The current trading price of JFL Life Sciences on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of JFL Life Sciences stood at ₹32.67 Cr

The latest P/E ratio of JFL Life Sciences as of 31-Dec-1969 is 5.10.

The latest P/B ratio of JFL Life Sciences as of 31-Dec-1969 is 0.74.

The 52-week high of JFL Life Sciences is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JFL Life Sciences is ₹131 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that JFL Life Sciences Ltd is a average quality company.

The key valuation ratios of JFL Life Sciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of JFL Life Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About JFL Life Sciences Ltd

The Company was incorporated as ‘JFL Life Sciences Private Limited’ on April 25, 2010 as a private limited company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution of company’s Shareholders passed in the extra-ordinary general meeting held on February 10, 2022, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to ‘JFL Life Sciences Limited’, and a fresh certificate of incorporation dated March 3, 2022 was issued to the Company by the Registrar of Companies, Gujarat at Ahmedabad.

Headquartered in Ahmedabad, Gujarat, JFL Life Sciences is engaged in the business of manufacturing of pharmaceutical products. The company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad. It is a manufacturing company, so its sales strategy is to sell its products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. It does not sell it under any brand name and it use the same strategy for both domestic & international market. The company exports its products majorly to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of its products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.

Business area of the company

JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS).

Major Events and Milestones

2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
2022: The company was converted from a private limited company to a public limited company and its name was changed to JFL Life Sciences Limited.

JFL Life Sciences Ltd (JFLLIFE)

JFL Life Sciences Ltd (JFLLIFE)

JFL Life Sciences stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of JFL Life Sciences - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JFL Life Sciences Ltd FAQs

About JFL Life Sciences Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

JFL Life Sciences Ltd (JFLLIFE)

JFL Life Sciences Ltd (JFLLIFE)

JFL Life Sciences stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of JFL Life Sciences - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

JFL Life Sciences Ltd FAQs

What is the share price of JFL Life Sciences?

What is the market cap of JFL Life Sciences?

What is the P/E ratio of JFL Life Sciences?

What is the P/B ratio of JFL Life Sciences?

What is the 52-week high and low of JFL Life Sciences?

What is the TTM revenue of JFL Life Sciences?

Is JFL Life Sciences Ltd a good quality company?

Is JFL Life Sciences Ltd undervalued or overvalued?

Is JFL Life Sciences Ltd a good buy now?

About JFL Life Sciences Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.